MedReg+1 Loveridge Acute Medicine

162 views
99 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
162
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

MedReg+1 Loveridge Acute Medicine

  1. 1. Developing people for health and healthcare Sepsis Acute Medicine 24th July The story behind sepsis management
  2. 2. Developing people for health and healthcare OUTLINE • To summarize the background behind sepsis management guidance • To understand why simplified guidelines are being promoted • • To consider briefly some of the possible future trends in sepsis care
  3. 3. Developing people for health and healthcare
  4. 4. Developing people for health and healthcare
  5. 5. Developing people for health and healthcare
  6. 6. Developing people for health and healthcare
  7. 7. Developing people for health and healthcare
  8. 8. Developing people for health and healthcare
  9. 9. Developing people for health and healthcare
  10. 10. Developing people for health and healthcare WHY WAS SIMPLIFICATION NEEDED? • Poor compliance with bundles • Guidance involves some complex measures • Mortality still stands at 30-35% • 36,800 lives lost annually in UK • Sepsis costs the NHS £2.5 billion
  11. 11. Developing people for health and healthcare THE SEPSIS SIX • Lactate • Blood cultures • Early antibiotic administration • Fluid resuscitation • Urine output monitoring • High flow oxygen
  12. 12. Developing people for health and healthcare WHY THE SEPSIS SIX?
  13. 13. Developing people for health and healthcare PREDICTED BENEFITS OF SEPSIS SIX • Achieving 80% compliance with Sepsis Six expected to save 15,000 lives per year in UK • …..and £170,000,000 • (Extrapolated from unpublished data relating to reduced length of stay)
  14. 14. Developing people for health and healthcare
  15. 15. Developing people for health and healthcare THE PROCESS TRIAL • Did not show statistically significant survival of patients treated with EGDT over and above less aggressive protocols or ‘usual care’
  16. 16. Developing people for health and healthcare WHAT NEXT? • PROMISE & ARISE trials • NICE Guideline due 2016 • Targeted in the National Outcomes Framework for the NHS Commissioning Board • Research into biomarkers, pathogen recognition, pathogenesis, targeted therapy
  17. 17. Developing people for health and healthcare REFERENCES AND FURTHER READING • Surviving sepsis campaign:International Guideline for Management of Severe Sepsis and Septic Shock 2012 http://www.sccm.org/Documents/SSC-Guidelines.pdf • Surviving the first hours in sepsis: getting the basics right (an intensivist’s perspective) J Antimicrob Chemother 2011: 66 Suppl 2 ii11-1123 • A randomized trial of protocol-based care for early septic shock; The Process Investigators NEJM 2014; 370:1683-1693 • Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline- based performance improvement program; Critical care medicine; August 2014 (42) Issue 8: 1794-1755
  18. 18. Developing people for health and healthcare References continued • The Ombudsman report 2013 • http://www.ombudsman.org.uk/__data/assets/pdf_file/0004/22666/ FINAL_Sepsis_Report_web.pdf • The UK Sepsis Trust report 2013 • http://www.england.nhs.uk/wp-content/uploads/2013/12/spesis- brief.pdf

×